Fecal Microbiota Transplantation clinical trials
Fecal Microbiota Transplantation is named as an intervention in 32 current clinical trials in our China, France, Canada, Spain, Denmark, Poland, Switzerland, Austria, Norway, South Korea and Taiwan registers. 15 are recruiting patients now. The most common phase is Phase 2. The sponsor with the most trials is Assistance Publique - Hôpitaux de Paris (3). The most-studied condition is Fecal Microbiota Transplantation.
Patient leaflets for Fecal Microbiota Transplantation
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Fecal Microbiota Transplantation
32 trialsRegisters list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Fecal Microbiota Transplantation
43 conditionsAll 43 conditions
| Condition (as registered) | Trials |
|---|---|
| Fecal Microbiota Transplantation | 3 |
| Hepatic Encephalopathy | 2 |
| TIPS | 2 |
| Crohn Disease | 2 |
| Fecal Microbiota Transplantation (FMT) | 2 |
| Anorexia Nervosa | 2 |
| Ulcerative Colitis | 2 |
| Irritable Bowel Syndrome | 2 |
| Immune Thrombocytopenia (ITP) | 1 |
| Radiation Induced Proctitis | 1 |
| Refractory Hepatic Encephalopathy | 1 |
| Type 1 Diabetes | 1 |
| Hepatocellular Carcinoma (HCC) | 1 |
| Gastrointestinal Neoplasms | 1 |
| Antineoplastic Agents | 1 |
| Drug-related Side Effects and Adverse Reactions | 1 |
| Humoral Immunodeficiency | 1 |
| Hematopoietic Stem Cell Transplantation | 1 |
| Obesity Type 2 Diabetes Mellitus | 1 |
| PCOS (Polycystic Ovary Syndrome) | 1 |
| Advanced Hepatocellular Carcinoma | 1 |
| Ulcerative Colitis (UC) | 1 |
| Inflammatory Bowel Disease | 1 |
| Acute Pancreatitis | 1 |
| Hidradenitis Suppurativa (HS) | 1 |
| Primary Sclerosing Cholangitis (PSC) | 1 |
| Inflammatory Bowel Disease (IBD) | 1 |
| Acute Leukemia in Remission | 1 |
| Myelodysplastic Syndromes | 1 |
| Myeloproliferative Syndrome | 1 |
| Hodgkin Lymphoma | 1 |
| Non Small Cell Lung Cancer | 1 |
| Respiratory Tract Neoplasm | 1 |
| Necrotizing Enterocolitis (NEC) | 1 |
| Necrotizing Enterocolitis of Newborn | 1 |
| Coronary Artery Disease | 1 |
| Type 2 Diabetes Mellitus (T2DM) | 1 |
| Graft Versus Host Disease in GI Tract | 1 |
| Renal Cell Carcinoma | 1 |
| Major Depressive Disorder | 1 |
| Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma | 1 |
| Breast Cancer | 1 |
| Graft vs Host Disease | 1 |
Sponsors
lead sponsor per trial+ 13 more sponsors in the trial list above.
By country register
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Fecal Microbiota Transplantation trials
How many clinical trials are testing Fecal Microbiota Transplantation?
32 current trials in our China, France, Canada, Spain, Denmark, Poland, Switzerland, Austria, Norway, South Korea and Taiwan registers name Fecal Microbiota Transplantation as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Fecal Microbiota Transplantation trials recruiting patients?
Yes. 15 of the 32 trials are recruiting: 10 with sites in China, 2 with sites in France, 1 with sites in Poland, 1 with sites in Austria and 1 with sites in Taiwan. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Fecal Microbiota Transplantation clinical trials?
Assistance Publique - Hôpitaux de Paris (3), Air Force Military Medical University, China (2), University Hospital, Clermont-Ferrand (2) and Peking University People's Hospital (1), among 28 lead sponsors in total. The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Fecal Microbiota Transplantation works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Fecal Microbiota Transplantation works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Fecal Microbiota Transplantation (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.